search button

Integrin-linked kinase: A hypoxia-induced anti-apoptotic factor exploited by cancer cells

  • Authors:
    • Elizabeth R. Abboud
    • Seth B. Coffelt
    • Yanira G. Figueroa
    • Kevin J. Zwezdaryk
    • Anne B. Nelson
    • Deborah E. Sullivan
    • Cindy B. Morris
    • Yan Tang
    • Barbara S. Beckman
    • Aline B. Scandurro

  • View Affiliations

  • Published online on: January 1, 2007     https://doi.org/10.3892/ijo.30.1.113
  • Pages: 113-122
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Based on cDNA microarray results, integrin-linked kinase (ILK) emerged as an interesting candidate in hypoxia-mediated survival mechanisms employed by cancer cells. This notion was confirmed here by the following observations: the 5' promoter region of the ilk gene contains hypoxia responsive elements (HRE) that bind hypoxia-inducible factor (HIF) transcription factor complexes and drive HRE-luciferase gene expression in reporter assays; ILK protein and kinase activity are induced following hypoxia; downstream targets of ILK signaling are induced following hypoxia treatment; inhibition of ILK leads to increased apoptosis; and HIF and ILK are co-localized within human cancer tissues. The identification of ILK as a player in hypoxia survival signaling employed by cancer cells further validates ILK as a unique target for cancer therapy.

Related Articles

Journal Cover

January 2007
Volume 30 Issue 1

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 4.5
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 9.6
  • CiteScore Rank: Q1: #66/404 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.88
  • SCImago Journal Rank (SJR): 1.099
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Abboud ER, Coffelt SB, Figueroa YG, Zwezdaryk KJ, Nelson AB, Sullivan DE, Morris CB, Tang Y, Beckman BS, Scandurro AB, Scandurro AB, et al: Integrin-linked kinase: A hypoxia-induced anti-apoptotic factor exploited by cancer cells. Int J Oncol 30: 113-122, 2007.
APA
Abboud, E.R., Coffelt, S.B., Figueroa, Y.G., Zwezdaryk, K.J., Nelson, A.B., Sullivan, D.E. ... Scandurro, A.B. (2007). Integrin-linked kinase: A hypoxia-induced anti-apoptotic factor exploited by cancer cells. International Journal of Oncology, 30, 113-122. https://doi.org/10.3892/ijo.30.1.113
MLA
Abboud, E. R., Coffelt, S. B., Figueroa, Y. G., Zwezdaryk, K. J., Nelson, A. B., Sullivan, D. E., Morris, C. B., Tang, Y., Beckman, B. S., Scandurro, A. B."Integrin-linked kinase: A hypoxia-induced anti-apoptotic factor exploited by cancer cells". International Journal of Oncology 30.1 (2007): 113-122.
Chicago
Abboud, E. R., Coffelt, S. B., Figueroa, Y. G., Zwezdaryk, K. J., Nelson, A. B., Sullivan, D. E., Morris, C. B., Tang, Y., Beckman, B. S., Scandurro, A. B."Integrin-linked kinase: A hypoxia-induced anti-apoptotic factor exploited by cancer cells". International Journal of Oncology 30, no. 1 (2007): 113-122. https://doi.org/10.3892/ijo.30.1.113